Accounting for the ion recombination factor in relative dosimetry of flattening filter free photon radiation

Evaluation of Ion Recombination Correction for Indigenously Developed Farmer Ion Chamber in Flattening Filter-Free Photon Beams

Purpose and Aim

Modern generation linear accelerator (linac) either generates X-rays with a flattening filter (WFF beam) or without flattening filter free (FFF beam). The FFF beams are associated with a significantly higher dose per pulse compared to WFF beams due to the absence of a flattening filter and the corresponding attenuation caused by it. This results in increased ion recombination and a larger saturation correction factor (ks). In accordance with the IAEA TRS 398 dosimetry protocol, ks is necessary for the accurate measurement of absorbed dose at a point in water. The objective of this study was to evaluate the ks for the indigenous FAR 65-GB ion chamber (IC) for the FFF X-rays.

Materials and Methods

The study was carried out on TrueBeam linac (Varian, A Siemens Healthineers company) which offers 6 MV WFF, 6 MV FFF, 10 MV WFF and 10 MV FFF beams. The two-voltage method was employed to measure ks in a solid water phantom at a depth of 10 cm for a FAR 65-GB and SNC 600c and 0.6cc PTW 30013 Farmer chambers at 100 cm and 150 cm source-to-chamber distances for a 10 cm × 10 cm field size.

Results

The ks values for the FAR 65-GB, PTW 30,013, and SNC 600c were 1.0055 (1.0113), 1.0051 (1.0071), and 1.0033 (1.0066) for the 6 MV WFF (FFF) beams, respectively, and 1.0066 (1.0178), 1.0061 (1.0137), and 1.0035 (1.0119) for the 10MV WFF (FFF) beams, respectively. The ks values calculated by two-voltage method matches with ks values obtained from Jaffe's plot. The chamber exhibited a linear dose-response up to 3000 cGy, beyond which a saturation effect was observed.

Conclusions

Our study reveals that this chamber is suitable for the reference dosimetry for the FFF beams.

Physics and biology of ultrahigh dose-rate (FLASH) radiotherapy: a topical review

Ultrahigh dose-rate radiotherapy (RT), or 'FLASH' therapy, has gained significant momentum following various in vivo studies published since 2014 which have demonstrated a reduction in normal tissue toxicity and similar tumor control for FLASH-RT when compared with conventional dose-rate RT. Subsequent studies have sought to investigate the potential for FLASH normal tissue protection and the literature has been since been inundated with publications on FLASH therapies. Today, FLASH-RT is considered by some as having the potential to 'revolutionize radiotherapy'. FLASH-RT is considered by some as having the potential to 'revolutionize radiotherapy'. The goal of this review article is to present the current state of this intriguing RT technique and to review existing publications on FLASH-RT in terms of its physical and biological aspects. In the physics section, the current landscape of ultrahigh dose-rate radiation delivery and dosimetry is presented. Specifically, electron, photon and proton radiation sources capable of delivering ultrahigh dose-rates along with their beam delivery parameters are thoroughly discussed. Additionally, the benefits and drawbacks of radiation detectors suitable for dosimetry in FLASH-RT are presented. The biology section comprises a summary of pioneering in vitro ultrahigh dose-rate studies performed in the 1960s and early 1970s and continues with a summary of the recent literature investigating normal and tumor tissue responses in electron, photon and proton beams. The section is concluded with possible mechanistic explanations of the FLASH normal-tissue protection effect (FLASH effect). Finally, challenges associated with clinical translation of FLASH-RT and its future prospects are critically discussed; specifically, proposed treatment machines and publications on treatment planning for FLASH-RT are reviewed.